Finland · Seed startup

Who invested in RNatives

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$1.6Mraised across 1 round since 2025, from 1 source

Latest round
Seed, $1.6MMay 2025
Investors
1
See who backed them

The rounds

  1. May 2025
    Seed$1.6M

    Source recorded

Founders and team

From RNatives's own website: 7 on the team.

  • Michael OkotResearch and Development Scientist
  • Mona HalmeResearch and Development Scientist
  • Nafee-Ul AlamResearch and Development Scientist
  • Nathaniel TettehResearch and Development Scientist
  • Reetta HirvonenResearch and Development Scientist
  • Stef BoschLaboratory Manager
  • Yasin ArafatResearch and Development Scientist

Everyone who backed them

Business FinlandAccelerator1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists RNatives as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Nordic Science InvestmentsVC firmPer its own site

Quick answers about RNatives

Who invested in RNatives?

RNatives's investors include Business Finland.

How much has RNatives raised?

RNatives has raised $1.6M across 1 round since 2025.

When did RNatives last raise?

RNatives's most recent round was a Seed of $1.6M in May 2025.

What was RNatives's biggest round?

Its most recent round, $1.6M in May 2025, is also its largest on record.

Who backed RNatives first?

RNatives's first round on record, in May 2025, was backed by Business Finland.

What stage is RNatives at?

RNatives's latest named round is a Seed, in May 2025.

Where is RNatives based?

RNatives is based in Finland.

Companies like RNatives

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.